Ce produit, fabriqué par le groupe Biocare Biotech, portant les dénominations « Bio Mix », sera disponible et destiné à toutes les tranches d’âge, des enfants aux personnes âgées. Lire la suite…
Insulin “Made in Algeria” conquers the Arab market: revenues of €250 million expected by 2025
A new era is dawning for the Algerian pharmaceutical industry. The Biocare Group has just announced the imminent launch next week of its first entirely locally-produced insulin pen, Bio Mix and Bio Rapid. Read more…